We are live on
!
Find out more
Bristol-Myers Squibb
BMY
BMY
2,515 hedge funds and large institutions have $97.9B invested in Bristol-Myers Squibb in 2026 Q1 according to their latest regulatory filings, with 267 funds opening new positions, 1,054 increasing their positions, 871 reducing their positions, and 149 closing their positions.
New
Increased
Maintained
Reduced
Closed
79% more first-time investments, than exits
New positions opened: 267 | Existing positions closed: 149
21% more repeat investments, than reductions
Existing positions increased: 1,054 | Existing positions reduced: 871
16% more funds holding in top 10
Funds holding in top 10: 31 → 36 (+5)
11% more capital invested
Capital invested by funds: $88.5B → $97.9B (+$9.39B)
3% more funds holding
Funds holding: 2,447 → 2,515 (+68)
4% less call options, than puts
Call options by funds: $1.48B | Put options by funds: $1.54B
1.48% less ownership
Funds ownership: 80.65% → 79.17% (-1.5%)
Holders
2,515
Holders Change
+68
Holders Change %
+2.78%
% of All Funds
30.97%
Holding in Top 10
36
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+16.13%
% of All Funds
0.44%
New
267
Increased
1,054
Reduced
871
Closed
149
Calls
$1.48B
Puts
$1.54B
Net Calls
-$63.5M
Net Calls Change
+$511M
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$1.02B |
| 2 |
JP Morgan Chase
New York
|
+$997M |
| 3 |
Two Sigma Investments
New York
|
+$401M |
| 4 |
SG Americas Securities
New York
|
+$366M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$345M |
Top Sellers
| 1 |
Capital International Investors
Los Angeles,
California
|
-$732M |
| 2 |
Charles Schwab
San Francisco,
California
|
-$595M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$485M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$417M |
| 5 |
BlackRock
New York
|
-$300M |